A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : GP / glycoprotein

[Related PubMed/MEDLINE]
Total Number of Papers: 3448
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   GP  (>> Co-occurring Abbreviation)
Long Form:   glycoprotein
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A Diacylglycerol Kinase Inhibitor, R-59-022, Blocks Filovirus Internalization in Host Cells. EBOV
2019 Achieving cross-reactivity with pan-ebolavirus antibodies. mAbs
2019 An integrin alphaIIbbeta3 intermediate affinity state mediates biomechanical platelet aggregation. ---
2019 Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine. EBOV
2019 Arbidol and other Low Molecular Weight Drugs That Inhibit Lassa and Ebola Viruses. EBOV, LASV
2019 Assessing cross-reactivity of Junin virus-directed neutralizing antibodies. BSL, JUNV, NAbs, trVLP
2019 Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma. BAZ, IL, STAT
2019 Clopidogrel-associated genetic variants on inhibition of platelet activity and clinical outcome for acute coronary syndrome patients. AA, ACS, BMI, CYP450, HPR, IPA, LOF, MACE, NPR, PCI, PON
2019 Complete protection of the BALB/c and C57BL/6J mice against Ebola and Marburg virus lethal challenges by pan-filovirus T-cell epigraph vaccine. ---
10  2019 Contrast agent dose and slow/no-reflow in percutaneous coronary interventions : Acase-control study of patients with non-ST-segment elevation acute coronary syndromes. NSTE-ACS
11  2019 Design of a multiepitopic Zaire ebolavirus protein and its expression in plant cells. EBOV, EVD
12  2019 Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding. HMWM, MCS, vWF
13  2019 Diagnosing Immune Thrombocytopenia. ITP
14  2019 Drug-induced immune thrombocytopenia: Mapping of the drug binding site to the membrane-proximal region of platelet GPIX. CHO, DIT
15  2019 Early human B cell response to Ebola virus in four U.S. survivors of infection. EVD, mAbs
16  2019 Expanding the watch list for potential Ebola virus antibody escape mutations. Ab100, Ab114, EBOV, EVD
17  2019 Hemizygosity for the gene encoding glycoproteinIbbeta is not responsible for macrothrombocytopenia and bleeding in patients with 22q11 deletion syndrome. 22q11DS
18  2019 HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2+ NK cells in Lassa virus infection. KIRs, LASV, NK, NP
19  2019 Intradermal SynCon Ebola GP DNA Vaccine is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers. EBOV, EP, ID, IM
20  2019 InVitro Measurement and Modeling of Platelet Adhesion on VWF-Coated Surfaces in Channel Flow. ---
21  2019 Mesenchymal stem cells-derived IL-6 activates AMPK/mTOR signaling to inhibit the proliferation of reactive astrocytes induced by hypoxic-ischemic brain damage. CCK, CNS, Co-IP, ELISA, GFAP, HIBD, IL-6, MSCs, mTOR, OGD, p-AMPKalpha, SD
22  2019 Naturally Occurring Single Mutations in Ebola Virus Observably Impact Infectivity. EBOV, NP, WT
23  2019 Nox2-mediated platelet activation by glycoprotein (GP) VI: Effect of rivaroxaban alone and in combination with aspirin. FXa, PA, sGPVI, sNox2-dp, TX
24  2019 Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib. BTK
25  2019 Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Tirofiban in Acute Ischemic Stroke. EVT, IVT
26  2019 Platelet glycoprotein VI and C-type lectin-like receptor 2 deficiency accelerates wound healing by impairing vascular integrity in mice. CLEC, TNF
27  2019 Post-Transfusion Purpura Mimicking Idiopathic Thrombocytopenic Purpura: A Case Report. HLA, ITP, MM, PBSCT, PTP
28  2019 Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting. BSL-2, CoV, HA, MERS-CoV, MLV, SARS-CoV
29  2019 Quantitative proteomic analysis reveals unfolded protein response involved in severe fever with thrombocytopenia syndrome virus infection. ATF6, GTV, HRTV, IRE1, iTRAQ, PERK, SFTS, SFTSV, SFTSV, UPR, XBP1
30  2019 Role of Platelet Size Revisited-Function and Protein Composition of Large and Small Platelets. ---
31  2019 Structure-Based in Silico Screening Identifies a Potent Ebolavirus Inhibitor from a Traditional Chinese Medicine Library. EBOV
32  2019 Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells. EBOV, EBOV, EBOV and NiV, IFN, NiV, VLP
33  2019 Vaccinomics strategy for developing a unique multi-epitope monovalent vaccine against Marburg marburgvirus. MHF
34  2018 A Fluorescently Labeled Marburg Virus Glycoprotein as a New Tool to Study Viral Transport and Assembly. MARV
35  2018 A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism. EBOV, TMD, VSV
36  2018 A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. EBOV, MARV, MVA, SUDV, TAFV
37  2018 A Replicating Single-Cycle Adenovirus Vaccine Against Ebola Virus. EBOV, RC-Ad, RD-Ad, SC-Ad
38  2018 A Single Amino Acid Change in the Marburg Virus Glycoprotein Arises during Serial Cell Culture Passages and Attenuates the Virus in a Macaque Model of Disease. MARV
39  2018 A single-chain antibody-CD39 fusion protein targeting activated platelets protects from cardiac ischaemia/reperfusion injury. ---
40  2018 A VSV-based Zika virus vaccine protects mice from lethal challenge. EBOV, VSV, ZIKV
41  2018 Akt-mediated platelet apoptosis and its therapeutic implications in immune thrombocytopenia. ITP, PS
42  2018 Alloimmunization in Congenital Deficiencies of Platelet Surface Glycoproteins: Focus on Glanzmann's Thrombasthenia and Bernard-Soulier's Syndrome. BSS, GT, HLA
43  2018 An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques. ---
44  2018 Analysis of adenovirus-induced immunity to infection with Listeria monocytogenes: Fading protection coincides with declining CD8 T cell numbers and phenotypic changes. ---
45  2018 Analysis of procoagulant phosphatidylserine-exposing platelets by imaging flow cytometry. EVs, PS
46  2018 Anti-c-Mpl antibodies in immune thrombocytopenia suppress thrombopoiesis and decrease response to rhTPO. ---
47  2018 Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors. EBOV
48  2018 Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap. mAbs
49  2018 Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens From Patients With Ebola Virus Disease. BDBV, EBOV, RESTV, SUDV
50  2018 Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements. ChIP, Co-IP, EBOV, trVLPs
51  2018 Characterization of a novel thogotovirus isolated from Amblyomma testudinarium ticks in Ehime, Japan: A significant phylogenetic relationship to Bourbon virus. OZV
52  2018 Combination antiplatelet treatment in coronary artery disease patients: A necessary evil or an overzealous practice? ---
53  2018 Construction and Characterization of a Humanized Anti-Epstein-Barr Virus gp350 Antibody with Neutralizing Activity in Cell Culture. EBV, hu, PTLD
54  2018 Correlates of vaccine-induced protective immunity against Ebola virus disease. PRIME, VSV, ZEBOV
55  2018 Correlations of inhaled NO with the cTnI levels and the plasma clotting factor in rabbits with acute massive pulmonary embolism. cTnI, GMP-140, NO, PE, vWF
56  2018 Critical role for cholesterol in Lassa fever virus entry identified by a novel small molecule inhibitor targeting the viral receptor LAMP1. LAMP1, LASV
57  2018 Current and future antiplatelet therapies: emphasis on preserving haemostasis. PI3Kbeta
58  2018 Delimiting the autoinhibitory module of von Willebrand factor. AIM, C-AIM, HDX, N-AIM, vWF
59  2018 Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors. ICCA
60  2018 Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art. ITP, MAIPA
61  2018 Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40. EBOV, EVD, mAbs, trVLPs, VP40
62  2018 Different effects of two mutations on the infectivity of Ebola virus glycoprotein in nine mammalian species. aa, EBOV, RESTV
63  2018 Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins. EBOV, EVD, MVA, NHPs, SUDV, VLPs, VP40
64  2018 DNA-launched RNA replicon vaccines induce potent anti-Ebolavirus immune responses that can be further improved by a recombinant MVA boost. DREP
65  2018 Dual monoclonal antibody-based sandwich ELISA for detection of in vitro packaged Ebola virus. ELISA, EVD, EVLPs, IFA, mAbs
66  2018 Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know? ---
67  2018 Ebola Virus Shed Glycoprotein Triggers Differentiation, Infection, and Death of Monocytes Through Toll-Like Receptor 4 Activation. ---
68  2018 Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates. BDBV, EVD, mAbs
69  2018 Fine mapping epitope on glycoprotein-Gn from Crimean-Congo hemorrhagic fever virus. BCEs, CCHFV, Gn, MSA
70  2018 Function of protein kinase CK2 in thrombus formation. ---
71  2018 Glycoprotein IIb/IIIa Inhibitors in Prevention and Rescue Treatment of Thromboembolic Complications During Endovascular Embolization of Intracranial Aneurysms. ---
72  2018 Growth-Adaptive Mutations in the Ebola Virus Makona Glycoprotein Alter Different Steps in the Virus Entry Pathway. EBOV, HR1, rVSV, VLPs, VSV
73  2018 High degree of correlation between Ebola virus BSL-4 neutralization assays and pseudotyped VSV BSL-2 fluorescence reduction neutralization test. EBOV, FRNT, GFP, PRNT, VSV
74  2018 High-resolution mapping of the polyclonal immune response to the human platelet alloantigen HPA-1a (PlA1). EGF1, FNAIT, muGPIIIa, PlA1, PSI
75  2018 High-throughput elucidation of thrombus formation reveals sources of platelet function variability. ---
76  2018 Human MHC-II with Shared Epitope Motifs Are Optimal Epstein-Barr Virus Glycoprotein 42 Ligands-Relation to Rheumatoid Arthritis. EBV, HLA, RA, SE
77  2018 Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus. ---
78  2018 Identification of Residues in Lassa Virus Glycoprotein Subunit 2 That Are Critical for Protein Function. GP1, GP2, LASV
79  2018 Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease. EBOV, EIAs, EVD, IEDB-AR, MARV, POC, RDTs, VHFs
80  2018 Immunogenicity of a Candidate Ebola Hemorrhagic Fever Vaccine in Mice Based on Controlled In Vitro Expression of Ebolavirus Glycoprotein. Ad, EBOV, EHF
81  2018 Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs. EBOV, VSV
82  2018 Immunogenicity of Recombinant Adenovirus Type 5 Vector-Based Ebola Vaccine Expressing Glycoprotein from the 2014 Epidemic Strain in Mice. Ad5-EBOV, GM
83  2018 Immunological tolerance to LCMV antigens differently affects control of acute and chronic virus infection in mice. CTLs, LCMV, NP, Tg
84  2018 Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge. EBOV, IM, MN
85  2018 InVivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model. DMAbs, EBOV
86  2018 Involvement of Surfactant Protein D in Ebola Virus Infection Enhancement via Glycoprotein Interaction. hSP-D, pSP-D, RESTV
87  2018 Lectin Affinity Plasmapheresis for Middle East Respiratory Syndrome-Coronavirus and Marburg Virus Glycoprotein Elimination. LAP, MARV, MERS-CoV
88  2018 Mass Cytometry Reveals Distinct Platelet Subtypes in Healthy Subjects and Novel Alterations in Surface Glycoproteins in Glanzmann Thrombasthenia. CD, FFC, GT, MC
89  2018 MMP-13 binds to platelet receptors alphaIIbbeta3 and GPVI and impairs aggregation and thrombus formation. MMP-13
90  2018 Mouse podoplanin supports adhesion and aggregation of platelets under arterial shear: A novel mechanism of haemostasis. TXA2, vWF
91  2018 Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. mAbs
92  2018 Non-natural amino acid peptide microarrays to discover Ebola virus glycoprotein ligands. ---
93  2018 P2X1 Receptors Amplify FcgammaRIIa-Induced Ca2+ Increases and Functional Responses in Human Platelets. mAb, NO, TLR
94  2018 Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors. EBOV, NP
95  2018 Percutaneous Non-Stenting Approach for Distal Simultaneous Multivessel Acute Coronary Occlusions. ---
96  2018 Platelet glycoprotein receptor Ib blockade ameliorates experimental cerebral ischemia-reperfusion injury by strengthening the blood-brain barrier function and anti-thrombo-inflammatory property. BBB, Mac-1, MCAO
97  2018 Platelet Signaling in Primary Haemostasis and Arterial Thrombus Formation: Part 1. vWF
98  2018 Porcine reproductive and respiratory syndrome virus neutralizing antibodies provide in vivo cross-protection to PRRSV1 and PRRSV2 viral challenge. PRRS, PRRSV
99  2018 Preparing Antigens Using a Baculovirus Expression System. ---
100  2018 Proteasome Inhibition with Bortezomib Induces Apoptosis of Long-Lived Plasma Cells in Steroid-Resistant or Relapsed Immune Thrombocytopaenia. ELISPOT, ITP, LLPCs